首页> 外文期刊>Journal of biomedical science. >The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs
【24h】

The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs

机译:高度保守的5'非翻译区是通过未修饰的和适当的2'修饰siRNA抑制肠道病毒71复制的有效靶标

获取原文
       

摘要

BackgroundEnterovirus 71 (EV71) is a highly infectious agent that plays an etiological role in hand, foot, and mouth disease. It is associated with severe neurological complications and has caused significant mortalities in recent large-scale outbreaks. Currently, no effective vaccine or specific clinical therapy is available against EV71.MethodsUnmodified 21 nucleotide small interfering RNAs (siRNAs) and classic 2~(′)-modified (2~(′)-O-methylation or 2~(′)-fluoro modification) siRNAs were designed to target highly conserved 5~(′) untranslated region (UTR) of the EV71 genome and employed as anti-EV71 agents. Real-time TaqMan RT-PCR, western blot analysis and plaque assays were carried out to evaluate specific viral inhibition by the siRNAs.ResultsTransfection of rhabdomyosarcoma (RD) cells with siRNAs targeting the EV71 genomic 5~(′) UTR significantly delayed and alleviated the cytopathic effects of EV71 infection, increased cell viability in EV71-infected RD cells. The inhibitory effect on EV71 replication was sequence-specific and dosage-dependent, with significant corresponding decreases in viral RNA, VP1 protein and viral titer. Appropriate 2~(′)-modified siRNAs exhibited similar RNA interference (RNAi) activity with dramatically increased serum stability in comparison with unmodified counterparts.ConclusionSequences were identified within the highly conserved 5~(′) UTR that can be targeted to effectively inhibit EV71 replication through RNAi strategies. Appropriate 2~(′)-modified siRNAs provide a promising approach to optimizing siRNAs to overcome barriers on RNAi-based antiviral therapies for broader administration.
机译:背景肠病毒71(EV71)是一种高度传染性的病原,在手足口病中起着病因作用。它与严重的神经系统并发症有关,并在最近的大规模暴发中造成大量死亡。目前尚无针对EV71的有效疫苗或特异性临床疗法。方法未修饰的21个核苷酸的小干扰RNA(siRNA)和经典的2〜(')-修饰的(2〜(')-O-甲基化或2〜(')-氟siRNA被设计为靶向EV71基因组的高度保守的5'(')非翻译区(UTR),并用作抗EV71试剂。通过实时TaqMan RT-PCR,Western印迹分析和噬菌斑分析来评估siRNA对病毒的特异性抑制作用。 EV71感染的细胞病变效应,在EV71感染的RD细胞中增加了细胞活力。对EV71复制的抑制作用是序列特异性和剂量依赖性的,病毒RNA,VP1蛋白和病毒滴度显着降低。合适的2〜(')修饰的siRNA与未修饰的siRNA表现出相似的RNA干扰(RNAi)活性,并且血清稳定性大大提高。结论在高度保守的5〜(')UTR中鉴定了可有效抑制EV71复制的序列。通过RNAi策略。适当的2〜(')-修饰的siRNA为优化siRNA克服基于RNAi的抗病毒疗法的障碍提供了一种有前途的方法,从而可以更广泛地应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号